1HIRSH J, FUSTER V, ANSELL J, et al. American heart association/American college of cardiology foundation guide to warfarin therapy[J]. Circulation, 2003, 107:1 692 - 1 711.
2GOLDSCHLAGER N, EPSTEIN A E, NAXXARELLI G, et al. Practical guidelines for clinicians who treat patients with amiodarone[J]. Arch Intern Med, 2000,160(12):1 741.
3FRISHMAN W H, SONNENBLICK E H. Cardiovascular pharmacotheraoeutics[M]. Me Graw Hill, 1997, 301 -303.
4BAUMAN J L, SANOSKI C A, CHAN L T. Pharmacokinetic and pharmacodynamic drug interaction with antiarrhythmic agents [J]. Cardiol Rev, 1997, 5:292 - 304.
5HEIMARK L D, WIENKERS L, KUNZE K, et al. The mechanism of the interaction between amiodarone and warfarin in humans[J]. Clin Pharmacol Ther, 1992, 51(4) :398 - 407.
6NAGANUMA M, SHIGA T, NISHIKATA K, et al. Role of desethylamiodarone in the anticoagulant effect of concurrent amiodarone and warfarin therapy[J]. J Cardiovasc Pharmacol Ther,2001, 6(4) : 363 - 367.
7O'REILLY R A, TRAGER W F, RETTIE A E, et al. Interraction of amiodarone with racemic warfarin and its separated enantiornorphs in humans[J]. Clin Pharmacol Ther, 1987, 42(3) :290 - 294.
8HIRMEROVA J, SUCHY D, MADR T. Dlouhotrvajici lekova interakce warfarinus amiodaronem. [ Long - term drug interaction of warfarin with amodarone]. Cas Lek Cesk, 2003, 142( 1 ) : 39- 42.
